openPR Logo
Press release

Animal Model Global Market Report 2024 - By Size, Share, Growth, Trends, Forecast To 2033

07-02-2024 07:11 AM CET | Health & Medicine

Press release from: The Business research company

Animal Model Market

Animal Model Market

"The new report published by The Business Research Company, titled Animal Model Global Market Report 2024 - Market Size, Trends, And Global Forecast 2024-2033, delivers an in-depth analysis of the leading size and forecasts, investment opportunities, winning strategies, market drivers and trends, competitive landscape, and evolving market trends.

As per the report, the animal model market size has grown strongly in recent years. It will grow from $1.76 billion in 2023 to $1.92 billion in 2024 at a compound annual growth rate (CAGR) of 8.7%. The animal model market size is expected to see strong growth in the next few years. It will grow to $2.69 billion in 2028 at a compound annual growth rate (CAGR) of 8.9%.

Download Free Sample Report @
https://www.thebusinessresearchcompany.com/sample.aspx?id=15510&type=smp

Growing Number Of Pharmaceutical Research And Development Activities Fuels Growth In The Animal Model Market
The growing pharmaceutical research and development investment activities are expected to propel the growth of the animal model market going forward. Pharmaceutical research and development is a complex process where science and innovation converge to create medical advancements. With the rise of innovative therapies, pursuing treatments for complex diseases, alongwith driving scientific curiosity and commercial opportunities in the healthcare sector moves research and development process. Animal models are crucial in pharmaceutical research and development for predicting drug efficacy, safety, and toxicity, providing insights into biological mechanisms, and aiding in developing new treatments by mimicking human physiological responses and disease progression in controlled settings. For instance, in June 2023, according to the European Federation of Pharmaceutical Industries and Associations, a Belgium-based trade association and lobbying organization, spending on pharmaceutical research and development across Europe was €44,500 ($47999) in 2022 and €42,533 million ($45877 million) in 2021, an increase of 7.82% from €39,442 ($42543 million) in 2020. Therefore, the growing pharmaceutical research and development investment is driving the animal model market.

Triple-Immunodeficient Mice And Their Impact On Biomedical Research
Major companies operating in the animal model market are focusing on developing innovative products, such as triple-immunodeficient animal models, to enhance the accuracy and reliability of preclinical studies, support advanced biomedical research, and facilitate the development of novel therapies for complex human diseases. Triple-immunodeficient animal models are specially engineered animals, typically mice, that lack three key immune system components. These models are invaluable in biomedical research, particularly for studying human diseases and developing new treatments. For instance, in January 2024, Charles River Laboratories International, Inc., a US-based pharmaceutical company, launched NCG mouse strains, a triple-immunodeficient mouse model for oncology research. NCG mice are triple immunodeficient, lacking functional/mature T, B, and NK cells, and exhibit reduced macrophage and dendritic cell function. These animal models can host xenograft cells, tissues, and human immune system components. This mouse model is ideal for research in oncology, immunology, tumor biology, infectious diseases, graft-versus-host disease (GvHD), diabetes, regenerative medicine, hematopoiesis, and tissue transplant studies. NCG mice can also create humanized mice by engrafting PBMCs or CD34+ stem cells, closely mimicking the human immune system.

The animal model market covered in this report is segmented -
1) By Animal Type: Mice, Rat, Guinea Pigs, Rabbits, Hamsters, Other Animal Types
2) By Technology: Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR), Embryonic Stem Cell Injection, Nuclear Transfer, Other Technologies
3) By Application: Drug Discovery And Development, Basic Research, Other Applications
4) By End User: Research Institutes, Educational Institutes, Pharmaceutical Companies, Contract Research Organizations

Buy Now & Get Exclusive Discount on this Report, Checkout link @
https://www.thebusinessresearchcompany.com/Discount?id=15510&type=discount

Major companies operating in the animal model market are Eurofins Scientific SE, Charles River Laboratories International Inc., Pharmaron Beijing Co Ltd, Inotiv Inc., Biocytogen, Taconic Biosciences Incorporation, Cyagen Biosciences, Trans Genic Incorporation, Crown Bioscience Incorporation, Harbor BioMed, PharmaLegacy, PsychoGenics, Biomere Biomedical Research Models Inc., Genoway S.A, Alloy Therapeutics, Janvier Labs, Hera Biolabs, Ozgene Pty Ltd, Transposagen Biopharmaceuticals Inc., KMT Hepatech Inc., AniLocus Inc., BioXpert, Harlan Sprague Dawley Inc.

Contents of the report:
1. Executive Summary
2. Animal Model Market Report Structure
3. Animal Model Market Trends And Strategies
4. Animal Model Market - Macro Economic Scenario
5. Animal Model Market Size And Growth
…..
27. Animal Model Market Competitor Landscape And Company Profiles
28. Key Mergers And Acquisitions
29. Future Outlook and Potential Analysis
30. Appendix

Explore the report store to make a direct purchase of the report @
https://www.thebusinessresearchcompany.com/report/animal-model-global-market-report

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ"

Learn More About The Business Research Company
The Business Research Company (www.thebusinessresearchcompany.com) is a leading market intelligence firm renowned for its expertise in company, market, and consumer research. With a global presence, TBRC's consultants specialize in diverse industries such as manufacturing, healthcare, financial services, chemicals, and technology, providing unparalleled insights and strategic guidance to clients worldwide.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Animal Model Global Market Report 2024 - By Size, Share, Growth, Trends, Forecast To 2033 here

News-ID: 3560949 • Views:

More Releases from The Business research company

Segment Evaluation and Major Growth Areas in the Personalized Testing and Supplements Market
Segment Evaluation and Major Growth Areas in the Personalized Testing and Supple …
The personalized testing and supplements sector is gaining remarkable traction, driven by advancements in technology and a rising consumer focus on tailored health solutions. As more individuals seek customized wellness options, this market is set to experience substantial expansion in the coming years. Here's an in-depth look at its current valuation, key players, significant trends, and the main market segments shaping its future. Market Valuation and Expansion Forecast for Personalized Testing
Top Players and Market Competition in the Skin Microbiome Industry
Top Players and Market Competition in the Skin Microbiome Industry
The skin microbiome market is emerging as a significant area of interest due to growing awareness about the critical role of skin health and innovative skincare technologies. As research advances and consumer preferences shift towards more natural and science-backed products, this market is set to undergo substantial growth. Let's explore the current market size, key players, driving factors, and upcoming trends shaping the skin microbiome industry. Projected Expansion in the Skin
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market Landscape
Key Strategic Developments and Emerging Changes Shaping the Upadacitinib Market …
The upadacitinib market is poised for significant expansion over the coming years, driven by advances in treatment options and increasing awareness of autoimmune diseases. This report delves into the market's current size, key drivers, major players, and the emerging trends shaping its future trajectory. Steady Growth Expected in Upadacitinib Market Size Through 2029 The market for upadacitinib is projected to reach $2.54 billion by 2029, growing at a robust compound annual
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Market
Analysis of Key Market Segments Driving the Alzheimer's Disease Diagnostic Marke …
The Alzheimer's disease diagnostic sector is rapidly evolving as advancements in technology and healthcare infrastructure open new possibilities for early detection and personalized treatment. With rising awareness and innovative approaches, this market is poised for significant growth in the coming years. Let's explore the current market size, key drivers, leading companies, and emerging trends that are shaping this critical healthcare field. Projected Market Size and Growth Trends in Alzheimer's Disease Diagnostics

All 5 Releases


More Releases for Animal

Animal Health Market Sets the Table for Continued Growth : Zoetis Animal Healthc …
Advance Market Analytics published a new research publication on "Animal Health Market Insights, to 2028" with 232 pages and enriched with self-explained Tables and charts in presentable format. In the Study you will find new evolving Trends, Drivers, Restraints, Opportunities generated by targeting market associated stakeholders. The growth of the Animal Health market was mainly driven by the increasing R&D spending across the world. Some of the key players profiled
Animal Antimicrobials and Antibiotics Market 2023 Growth and Development By Bion …
Antibiotics, also called antibacterials, are a type of antimicrobial drug used in the treatment and prevention of bacterial infections. They may either kill or inhibit the growth of bacteria. Animal Antimicrobials and Antibiotics includes Premixes, Oral Powders, Oral Solutions and Injections on the base of classification, which represent 12.4%, 14.4%, 10.4% and 56.6% of global Animal Antimicrobials and Antibiotics market. Get Sample Copy: https://www.worldwidemarketreports.com/sample/273708 Farm Animals and Companion Animals are the
Animal Healthcare Market Analysis Focusing on Top Key Players - Merck, Bayer Ani …
Worldwide Market Reports recently released on the Animal Healthcare market for the forecast period, 2017 – 2022 is involved in screening the business environment and the companies operating in the Animal Healthcare industry. Importantly, the research sheds a lot of light on their winning strategies to help stakeholders, business owners, and field marketing executives stay ahead in the competition. Besides, the industry is thoroughly weighed upon on the basis of
Animal Model Market trends, Animal Model Market growth, Animal Model Market size …
Key Findings of Animal Model Market Developing Regions to Overpower Developed Ones With Regard to Demand The Asian territory is on the verge of evolving as the next big destination for animal models. This growth can be attributed to various factors such as American and European pharmaceutical companies diversifying their research activities to curtail extra expenses and save costs. Although U.S and Europe have retained their legacy in the global market, their
Animal Growth Promoter Market Outlook To 2023 – Bayer Animal Health, Biomin, B …
Nov 2018, New York USA (News)- Different categories of feed additives for farm animals are referred to as natural growth promoters (NGPs) or non-antibiotic growth promoters. They are commonly regarded as favorable alternatives to antibiotic growth promoters (AGPs) in livestock production. NGPs include predominantly organic acids, probiotics, prebiotics, synbiotics, phytogenics, tannins, feed enzymes and immune stimulants, an ongoing search for alternatives has created a large variety of NGPs for pigs,
Animal Antimicrobials and Antibiotics Market Key Players : Animal Health, Bayer …
The term antibiotic or antimicrobial is used for those agents who kill or inhibit the growth of microorganism. The antimicrobials products have significant benefits to the animal and to human food safety. There are researches, which have proven that an increase in the rate of animal illness results in higher rate of human illness. Therefore, livestock dealers depend on animal antibiotics to provide safe food. The scope of this report